Observational research on NCDs in HIV-positive populations: conceptual and methodological considerations

scientific article

Observational research on NCDs in HIV-positive populations: conceptual and methodological considerations is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/QAI.0000000000000253
P932PMC publication ID4317266
P698PubMed publication ID25117964

P50authorMatthias EggerQ19996372
Amy C JusticeQ42395670
Constantin T YiannoutsosQ83393956
P2093author name stringMaya Petersen
P2860cites workHIV and noncommunicable cardiovascular and pulmonary diseases in low- and middle-income countries in the ART era: what we know and best directions for future researchQ26827746
Association of HIV and ART with cardiometabolic traits in sub-Saharan Africa: a systematic review and meta-analysisQ27000959
HIV, tuberculosis, and noncommunicable diseases: what is known about the costs, effects, and cost-effectiveness of integrated care?Q27010874
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaborationQ28222847
The end of AIDS: HIV infection as a chronic diseaseQ28300749
Prognosis Research Strategy (PROGRESS) 3: prognostic model researchQ28709215
Profile: the Karonga Health and Demographic Surveillance SystemQ28727176
Profile: Agincourt health and socio-demographic surveillance systemQ28728205
HIV, aging and continuity care: strengthening health systems to support services for noncommunicable diseases in low-income countriesQ43679820
Risk of non-AIDS-related mortality may exceed risk of AIDS-related mortality among individuals enrolling into care with CD4+ counts greater than 200 cells/mm3.Q44203105
The Veterans Affairs Healthcare System: A unique laboratory for observational and interventional researchQ45332693
Assessing the effectiveness of antiretroviral adherence interventions. Using marginal structural models to replicate the findings of randomized controlled trialsQ46120113
Smoking among HIV positive New Yorkers: prevalence, frequency, and opportunities for cessationQ46382491
Asymptotic optimality of likelihood-based cross-validationQ46523230
Profile: the KEMRI/CDC Health and Demographic Surveillance System--Western KenyaQ46587953
Super learnerQ46932589
The unseen sample in cohort studies: estimation of its size and effect. Multicenter AIDS Cohort StudyQ47421718
Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment.Q51809092
Development and verification of a "virtual" cohort using the National VA Health Information System.Q51937405
PHosphatidylethanol (PEth) concentrations in blood are correlated to reported alcohol intake in alcohol-dependent patients.Q51943448
Hiding in the shadows of the HIV epidemic: obesity and hypertension in a rural population with very high HIV prevalence in South AfricaQ55546962
Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort StudyQ56530639
Differences in cardiovascular risk factors in rural, urban and rural-to-urban migrants in PeruQ28744385
Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyondQ29614697
Marginal structural models and causal inference in epidemiologyQ29619287
Responding to the HIV pandemic: the power of an academic medical partnership.Q30363938
The global cardiovascular risk transition: associations of four metabolic risk factors with national income, urbanization, and Western diet in 1980 and 2008.Q30428113
Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic reviewQ33302944
Sampling-based approaches to improve estimation of mortality among patient dropouts: experience from a large PEPFAR-funded program in Western KenyaQ33388709
Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis.Q33460434
Assessing the generalizability of prognostic informationQ33540894
Systemic effects of inflammation on health during chronic HIV infectionQ33577551
Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007-2009: systematic reviewQ33619740
Correcting mortality for loss to follow-up: a nomogram applied to antiretroviral treatment programmes in sub-Saharan AfricaQ33803701
Correcting for mortality among patients lost to follow up on antiretroviral therapy in South Africa: a cohort analysisQ33838306
The burden of selected chronic non-communicable diseases and their risk factors in Malawi: nationwide STEPS surveyQ33918330
Biomarker discovery using targeted maximum-likelihood estimation: application to the treatment of antiretroviral-resistant HIV infectionQ33938373
Causal effects in clinical and epidemiological studies via potential outcomes: concepts and analytical approachesQ33960730
Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic reviewQ33979497
Estimating loss to follow-up in HIV-infected patients on antiretroviral therapy: the effect of the competing risk of death in Zambia and SwitzerlandQ34113515
Noncommunicable diseases in HIV infection in low- and middle-income countries: gastrointestinal, hepatic, and nutritional aspectsQ34157953
HIV treatment as prevention: models, data, and questions--towards evidence-based decision-makingQ34339523
An experimental design for the development of adaptive treatment strategiesQ34374570
A systematic review of Demographic and Health Surveys: data availability and utilization for researchQ34380157
Leveraging rapid community-based HIV testing campaigns for non-communicable diseases in rural UgandaQ34391572
Recent developments in hiv treatment and their dissemination in poor countriesQ34400513
Hypertension and obesity in adults living in a high HIV prevalence rural area in South AfricaQ34452281
Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomesQ34556854
Genes, environment and the value of prospective cohort studiesQ34567044
Tackling non-communicable diseases in low- and middle-income countries: is the evidence from high-income countries all we need?Q34574778
Immunologic basis of cardiovascular disease in HIV-infected adultsQ34638205
Rates and factors associated with major modifications to first-line combination antiretroviral therapy: results from the Asia-Pacific regionQ34804309
An internationally generalizable risk index for mortality after one year of antiretroviral therapy.Q34813110
Virologic and immunologic response, clinical progression, and highly active antiretroviral therapy adherence.Q35057780
Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmesQ35111146
Prognosis of children with HIV-1 infection starting antiretroviral therapy in Southern Africa: a collaborative analysis of treatment programsQ35148237
Global health: the Fogarty International Center, National Institutes of Health: vision and mission, programs, and accomplishmentsQ35215367
The first decade of antiretroviral therapy in AfricaQ35337985
Challenges in the detection, prevention, and treatment of HIV-associated malignancies in low- and middle-income countries in AfricaQ35360144
A marginal structural model to estimate the causal effect of antidepressant medication treatment on viral suppression among homeless and marginally housed persons with HIVQ35526694
Treatment outcomes of a stage 1 cognitive-behavioral trial to reduce alcohol use among human immunodeficiency virus-infected out-patients in western KenyaQ35529225
Nurturing the global workforce in clinical research: the National Institutes of Health Fogarty International Clinical Scholars and Fellows ProgramQ35576126
A causal framework for understanding the effect of losses to follow-up on epidemiologic analyses in clinic-based cohorts: the case of HIV-infected patients on antiretroviral therapy in AfricaQ35963111
Building capacity in health research in the developing world.Q36006023
Optimizing randomized trial designs to distinguish which subpopulations benefit from treatmentQ36145026
HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working GroupQ36147395
Cohort Profile: the international epidemiological databases to evaluate AIDS (IeDEA) in sub-Saharan AfricaQ36301925
Prognosis research strategy (PROGRESS) 1: a framework for researching clinical outcomesQ36591044
The general population cohort in rural south-western Uganda: a platform for communicable and non-communicable disease studiesQ36693458
Predictive accuracy of the Veterans Aging Cohort Study index for mortality with HIV infection: a North American cross cohort analysisQ36747893
Behavioral aspects of HIV care: adherence, depression, substance use, and HIV-transmission behaviorsQ36821663
Cohort Profile: Caribbean, Central and South America Network for HIV research (CCASAnet) collaboration within the International Epidemiologic Databases to Evaluate AIDS (IeDEA) programmeQ36936569
Sampling-based approach to determining outcomes of patients lost to follow-up in antiretroviral therapy scale-up programs in AfricaQ37012911
Impact of definitions of loss to follow-up on estimates of retention, disease progression, and mortality: application to an HIV program in MozambiqueQ37127890
Impact of definitions of loss to follow-up (LTFU) in antiretroviral therapy program evaluation: variation in the definition can have an appreciable impact on estimated proportions of LTFU.Q37138868
Non-ignorable loss to follow-up: correcting mortality estimates based on additional outcome ascertainmentQ37384915
Advances in measuring the effect of individual predictors of cardiovascular risk: the role of reclassification measuresQ37435521
Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapyQ37496608
Factors contributing to risk for cancer among HIV-infected individuals, and evidence that earlier combination antiretroviral therapy will alter this riskQ37712406
PEPFAR, health system strengthening, and promoting sustainability and country ownershipQ38026476
HIV and metabolic, body, and bone disorders: what we know from low- and middle-income countriesQ38239435
Mental, neurological, and substance use disorders in people living with HIV/AIDS in low- and middle-income countriesQ38239436
HIV-associated renal and genitourinary comorbidities in AfricaQ38239437
Statin treatment for primary prevention of vascular disease: whom to treat? Cost-effectiveness analysis.Q38464443
Investigator bias and interviewer bias: the problem of reporting systematic error in epidemiologyQ38573230
Translating global health research aims into action: the example of the ALPHA network.Q38873076
Gender and the use of antiretroviral treatment in resource-constrained settings: findings from a multicenter collaborationQ38876759
Toward a systemic research agenda for addressing the joint epidemics of HIV/AIDS and noncommunicable diseasesQ39020368
Trends in retention on antiretroviral therapy in national programs in low-income and middle-income countriesQ39512357
Targeted Maximum Likelihood Estimation for Dynamic and Static Longitudinal Marginal Structural Working Models.Q39841951
P407language of work or nameEnglishQ1860
P304page(s)S8-16
P577publication date2014-09-01
P1433published inJournal of Acquired Immune Deficiency SyndromesQ6294722
P1476titleObservational research on NCDs in HIV-positive populations: conceptual and methodological considerations
P478volume67 Suppl 1

Reverse relations

cites work (P2860)
Q37037325Clinical Performance Validation of 4 Point-of-Care Cervical Cancer Screening Tests in HIV-Infected Women in Zambia
Q90612746Comorbidity of HIV, hypertension, and diabetes and associated factors among people receiving antiretroviral therapy in Bahir Dar city, Ethiopia
Q33777533Comprehensiveness of HIV care provided at global HIV treatment sites in the IeDEA consortium: 2009 and 2014.
Q57990800Does mode of delivery matter for smoking cessation interventions? A meta-analysis of mHealth versus face-to-face interventions for smoking cessation among people living with HIV (Preprint)
Q57990802Does mode of delivery matter for smoking cessation interventions? A meta-analysis of mHealth versus face-to-face interventions for smoking cessation among people living with HIV (Preprint)
Q92580442Emergency care surveillance and emergency care registries in low-income and middle-income countries: conceptual challenges and future directions for research
Q35750131Glucose Metabolism Disorders, HIV and Antiretroviral Therapy among Tanzanian Adults
Q27010874HIV, tuberculosis, and noncommunicable diseases: what is known about the costs, effects, and cost-effectiveness of integrated care?
Q26786887Innovations in health and demographic surveillance systems to establish the causal impacts of HIV policies
Q92859377Non-communicable diseases in sub-Saharan Africa: a scoping review of large cohort studies
Q64079045Noncommunicable disease burden among HIV patients in care: a national retrospective longitudinal analysis of HIV-treatment outcomes in Kenya, 2003-2013
Q64137244Noncommunicable diseases among HIV-infected persons in low-income and middle-income countries: a systematic review and meta-analysis
Q36032285Population-Based Assessment of Hypertension Epidemiology and Risk Factors among HIV-Positive and General Populations in Rural Uganda
Q37652861Predictors of hypertension in an urban HIV-infected population at the University of Calabar Teaching Hospital, Calabar, Nigeria
Q52609186Strengthening Routine Data Systems to Track the HIV Epidemic and Guide the Response in Sub-Saharan Africa.
Q54518743Strengthening of information systems and research to tackle HIV and non-communicable diseases.

Search more.